[DOI] [PubMed] [Google Scholar] 44.Yabe D, Nakamura J, Kaneto H, et al
As per the agreement, the California-based company will leverage its $260 million peptide production plant in Sejong, South Korea, which is expected to open in 2026
This helps people avoid overeating by increasing feelings of fullness
The medication does not affect bleeding, clotting, or menstrual flow
Combining your GLP-1 medication with healthy habits and reliable support tools like DISONCARE ensures more predictable results and a smoother treatment experience
Left unaddressed, these issues can increase the risk of type 2 diabetes , cardiovascular disease , and mental health concerns